With the acknowledgment of microgravity-induced atrophy occurring even with MuRF1 deletion in mice, the mechanism between hypercholesterolemia and chronic inflammation in skeletal muscle must be investigated further to elucidate potential therapeutic targets. This evidence concerns the gene TRIM63 and familial hypercholesterolemia.